Chronic Disease Management Global Market Report 2023– By Service (Consulting Service, Implementation Service, Educational Service), By Delivery Mode (On premise, Cloud based, Web based), By Disease Type (Cardiovascular Diseases, Diabetes, Cancer, Asthma, Chronic Obstructive Pulmonary Disorders), By End User (Providers, Payers) – Market Size, Trends, And Global Forecast 2023-2032

Preventive healthcare technologies include screenings, check-ups, and patient counselling to identify and prevent health problems. Preventive healthcare technology devices are more commonly used to measure daily lives health patterns like blood oxygen saturation, heart rate, blood pressure, and sleep patterns. The preventive healthcare technologies and services are used to take measures and identify future illnesses and treatment by the healthcare providers. The main types of preventive healthcare technologies and services market are early detection and screening technologies, vaccines, chronic disease management technologies, advanced technologies to reduce errors. Early detection and screening technologies are used to identify future health conditions of patients. The early detection and screening technologies include x-ray, CT, ultrasound, magnetic resonance imaging (MRI). The applications of preventive healthcare technologies and services are in hospitals and clinics. The global preventive healthcare technologies and services market is segmented - 1) By Type: Early Detection and Screening Technologies, Vaccines, Chronic Disease Management Technologies, Advanced Technologies to Reduce Errors 2) By Application: Hospitals, Clinics The global preventive healthcare technologies and services market size grew from $220.95 billion in 2022 to $251.83 billion in 2023 at a compound annual growth rate (CAGR) of 14.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The preventive healthcare technologies and services market size is expected to grow to $441.5 billion in 2027 at a CAGR of 15.1%. An increase in the older population pool is increasing demand for the preventive healthcare technologies and services market. Medical problems are known to increase with age, due to this preventing or identifying problems at an early stage can decrease the risk and intensity of the issue. According to the United Nations survey, an intergovernmental organization, there were around 727 million persons that were aged above 65 years or above in 2020 and it is projected to reach around 1.5 billion in 2050. This increase in the aged people population can also directly impact the preventive healthcare technologies market. Major players in the preventive healthcare technologies and services market is Omnicell Inc., Merck & Co. Inc., McKesson Corporation, GlaxoSmithKline plc., Medtronic, Quest Diagnostics Inc., Alere, Myriad Genetics Inc., Omron Healthcare, Pfizer Inc., Sanofi, Healthway, Inc., Tivity Health, Dilon Technologies Inc., Novx Systems, Scripto LLC, Viatronix Inc., U-Systems Inc. The use of artificial intelligence (AI) as a preventive healthcare technique is a rising trend in the preventive healthcare technologies and services market. Many medical conditions such as identifying type 1 diabetes, indications of Alzheimer's, and predicting breast cancer, cardiovascular diseases can be identified using the advanced AI technologies. Some orthopedic spine surgery experts from Boston-based Massachusetts General Hospital suggest that machine learning and AI can also predict personalized and accurate assumptions of where fractures will happen on a patient based on the history of the patient and the historic database available. Similarly, in November 2020, Medtronic, American-Irish registered medical device company acquired France based company, Medicrea that provides AI-driven surgical planning and predictive modelling tools which helps to improve the quality of spine management. In November 2021, Hellman & Friedman and Bain Capital, a private equity firm, acquired Athenahealth, Inc for $17 billion. This acquisition will help Athenahealth become the largest and most innovative provider of cloud-based electronic medical records and physician practice solutions in the USA. Athenahealth, Inc is a cloud computing vendor that enhances the clinical quality, operational efficiency, and delivery of preventive care to many patients in the US. North America was the largest region in the preventive healthcare technologies and services market in 2022. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the preventive healthcare technologies and services market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the preventive healthcare technologies and services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The preventive healthcare technologies market includes revenues earned by entities remote patient monitoring, 5G-enabled devices, and wearable sensors. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The preventive healthcare technologies and service market research report is one of a series of new reports from The Business Research Company that provides preventive healthcare technologies and service market statistics, including preventive healthcare technologies and service industry global market size, regional shares, competitors with a preventive healthcare technologies and service market share, detailed preventive healthcare technologies and service market segments, market trends and opportunities, and any further data you may need to thrive in thepreventive healthcare technologies and service industry. This preventive healthcare technologies and service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Healthcare IT integration refers to a variety of electronic methods that are used to manage patient data for both individual patients and groups of patients, including information about people's health and medical care. It includes a variety of electronic methods used for systematic collection of real-time data from patients in digital format to create a healthcare ecosystem. Healthcare IT integration allows information such as patients' medical history, current treatment information, treatment plans, important dates for treatments, laboratory reports, test results, and others to be retrieved instantly and securely available by authorised users to improve the quality of healthcare. The main components of healthcare IT integration include products and services. Healthcare IT integration products are used in the integration of healthcare data such as interfaces and integration engines, medical device integration software, media integration software, and other integration tools. The different applications of healthcare IT integration include clinic integration, radiology integration, lab integration, hospital integration, and other applications. The global healthcare it integration market is segmented - 1) By Component: Product, Service 2) By Application: Clinic Integration, Radiology Integration, Lab Integration, Hospital Integration, Other Applications The global healthcare IT integration market size will grow from $3.99 billion in 2022 to $4.5 billion in 2023 at a compound annual growth rate (CAGR) of 12.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the healthcare IT integration market size is expected to grow to $7.42 billion in 2027 at a CAGR of 13.3%. The rapid adoption of electronic health records by physicians is significantly contributing to the growth of the healthcare IT integration market. The electronic health record is a systematic collection of real-time data of patients in digital format by physicians or hospitals, whose information is instantly and securely available by authorised users. Electronic health records require healthcare IT software and its integration into healthcare institutes for smooth functioning and maintenance of vast medical data. For instance, in 2021, according to HealthIT.gov, a US-based official website for health information technology, a certified EHR was adopted by virtually all non-federal acute care hospitals (96%) and nearly 4 in 5 all office-based physicians (78%) in the United States. Therefore, the rapid adoption of electronic health records by physicians is expected to propel the growth of the healthcare IT integration market over the coming years. Major players in the healthcare IT integration market are Infor, InterSystems Corporation, Cerner Corporation, Orion Health, NXGN Management, LLC, iNTERFACEWARE Inc., Allscripts Healthcare, LLC, Epic Systems Corporation, AVI-SPL, Inc., Corepoint Health, Oracle, GE Healthcare, IBM Corporation, Siemens Healthcare GmbH, and Qualcomm Life, Inc. Technological advancement in healthcare IT integration is the key trend being followed by the companies operating in the healthcare IT integration market. For instance, in 2021, Lyniate, an American-based healthcare IT integration g followed by the companies operating in the healthcare IT integration market. For instance, in 2021, Lyniate, an American-based healthcare IT integration company, launched its new product, Lyniate Envoy, with API technology from Datica Inc., which offers turnkey data exchange with any healthcare IT system, including Corepoint and Rhapsody. It also allows users to network with approximately over 1300 healthcare organizations for maintaining and monitoring patients’ data exchange using FHIP, C-CDA, DICOM, and others. In July 2022, Healthcare Performance Group, Inc., (HPG), a US-based company operating in EHR technology acquired Health Data Specialists, LLC (HDS) for an undisclosed amount. Through this acquisition, Healthcare Performance Group, Inc., (HPG) aims to expand its ability to deliver results-oriented solutions for healthcare IT systems, applications, and workflows. Health Data Specialists, LLC (HDS) is a US-based company operating in healthcare information technology consulting services. North America was the largest region in the healthcare IT integration market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare IT integration report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the healthcare IT integration market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The healthcare IT integration market includes revenues earned by entities by providing seamless information exchange among doctors and patients, and improving performance management. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The Healthcare IT Integration market research report is one of a series of new reports from The Business Research Company that provides healthcare IT integration market statistics, including healthcare IT integration industry global market size, regional shares, competitors with a healthcare IT integration market share, detailed healthcare IT integration market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare IT integration industry. This healthcare IT integration market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Healthcare Interoperability system refers to the exchange of healthcare information between two or more systems. Healthcare interoperability enables seamless data sharing across healthcare organizations with the patient’s consent. Electronic health records (EHRs) along with health information exchange (HIE) services must be optimized and adopted by every healthcare firm to implement interoperability functionalities. Interoperability achievement depends on five key components namely, privacy and security, standards, rules of engagement, adoption & optimization, and financial & clinical incentives. The main types in the healthcare interoperability solutions market are software solutions and services. The services market in the healthcare interoperability solutions consists of sales of services by entities (organizations, sole traders, and partnerships) that are used for patient care and safety. The software solutions used in healthcare interoperability solutions include EHR interoperability solutions, Lab system solutions, imaging system solutions, healthcare information exchange solutions, enterprise solutions, and other healthcare solutions. The healthcare interoperability solution market operates at the foundation level, structural level, and semantic level. Healthcare interoperability solutions are used by healthcare providers, healthcare payers, and pharmacies. The global healthcare interoprability solutions market is segmented - 1) By Type: Software Solutions, Services 2) By Software Solutions: Eletronic Health Record (EHR) Interoperability Solutions, Lab System Interoperability Solutions, Imaging System Interoperability Solutions, Healthcare Information Exchange Interoperability Solutions, Enterprise Interoperability Solutions, Other Healthcare Interoperability Solutions 3) By Level of Interoperability: Foundational Interoperability, Structural Interoperability, Semantic Interoperability 4) By End User: Healthcare Providers, Healthcare Payers, Pharmacies The global healthcare interoperability solutions market size will grow from $3.82 billion in 2022 to $4.3 billion in 2023 at a compound annual growth rate (CAGR) of 12.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the healthcare interoperability solutions is expected to grow to $7.05 billion in 2027 at a CAGR of 13.2%. The government initiatives to enhance patient care and safety are expected to propel the growth of the healthcare interoperability solutions market over the coming years. The shortcoming in the healthcare system is arising due to its increasing demand in public leading to Covid -19 pandemic. Government authorities across the globe such as the Canter for Medicare & Medicaid Services (CMS) have set the goal of increasing healthcare availability by implementing advanced technologies to better treat the patients. For instance, in May 2020, CMS Interoperability and Patient Access Final Rule is published by CMS. The rule is promoting the policies that enable advanced interoperability and access to health information for all stakeholders. Major players in the healthcare interoperability solutions market are Cerner Corporation, Epic Systems Corporation, Koninklijke Philips N.V., ViSolve Inc., Jitterbit Inc., Quality Systems Inc., Orion Health Group Limited, Infor Inc., Allscripts Healthcare Solutions Inc., InterSystems Corporation, OSP, Interfaceware Inc., Virtusa Corp, Summit Healthcare Services Inc., Mphrx Inc., WIPRO Ltd., Emids Technologies Inc., Nalashaa Healthcare, and Deevita LLC. The increasing investments in the healthcare sector of emerging economies is a key trend gaining popularity in the healthcare interoperability solutions market. Due to the emergence of Covid, the global healthcare industry is growing tremendously leading to the increasing need for resources and attention. During the pandemic situation, Fast Healthcare Interoperability Resources (FHIR) got more attention as it uses the internet to access healthcare data. Emerging countries moving towards eHealth are adopting interoperability solutions as their first step towards digitization. The entrenched and legacy health systems are driving investments in digital health models from a wide range of economies globally. In September 2021, an America-based health information technology solution provider expanded its investment in the i.s.h.med electronic health record (EHR). i.s.h.med is the hospital information system that is integrated with the SAP solutions. Cerner’s this investment leads to its strong position in healthcare digitization. In February 2020, Symplr, an American-based company specializing in healthcare governance, risk management, and compliance (GRC) software as a service (SaaS) platform acquired The Patient Safety Company (TPSC) for an undisclosed amount. Through this acquisition, Symplr will be able to include patient safety and incident tracking and reporting portfolios in its end-to-end GRC SaaS solutions. The Patient Safety Company (TPSC) is a Netherland-based ICT solution provider in the healthcare industry. North America was the largest region in the healthcare interoperability solutions market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare interoperability solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the healthcare interoperability solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The healthcare interoperability market includes revenues earned by entities by providing DevOps services, security as a service, identity and access management services, data security services, cloud infrastructure security service. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The healthcare interoperability solutions market research report is one of a series of new reports from The Business Research Company that provides healthcare interoperability solutions market statistics, including healthcare interoperability solutions industry global market size, regional shares, competitors with a healthcare interoperability solutions market share, detailed healthcare interoperability solutions market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare interoperability solutions industry. This healthcare interoperability solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Precision medicine refers to a type of medication that prevents, detects, or treats disease using knowledge about a person's own genes or proteins. In order to choose a treatment that may be most effective for a person, precision medicine considers their genetics, environment, and lifestyle. The main technologies involved in precision medicine are bioinformatics, big data analytics, drug discovery, gene sequencing, companion diagnostics, and others. Bioinformatics technologies involve the application of computational tools to organize, analyze, understand, visualize and store information associated with biological macromolecules. It is used in oncology, respiratory diseases, central nervous disorders, immunology, genetic diseases, others and is implemented in various sectors such as hospitals and clinics, pharmaceuticals, diagnostic companies, healthcare, and IT firms, among others. The global precision medicine market is segmented - 1) By Technology: Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technologies 2) By Application: Oncology, Respiratory Diseases, Central Nervous System Disorders, Immunology, Genetic Diseases, Other Applications 3) By End-User: Hospitals And Clinics, Pharmaceuticals, Diagnostic Companies, Healthcare And IT Firms, Other End-Users The global precision medicine market size will grow from $83.43 billion in 2022 to $95 billion in 2023 at a compound annual growth rate (CAGR) of 13.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The precision medicine market size is expected to grow to $157.26 billion in 2027 at a CAGR of 13.4%. The rising prevalence of cancer is projected to fuel the growth of the precision medicine market in the coming years. Cancer is one of the main causes of death worldwide, with one out of every five individuals developing cancer at some point in their lives. Precision medicine in cancer entails analyzing DNA from tumors to find mutations or other genetic abnormalities that cause cancer. Physicians may therefore be able to choose a treatment for a specific patient's cancer that best fits, or targets, the tumor DNA alterations. For instance, according to recent predictions from the International Agency for Research on Cancer (IARC), the global cancer burden increased to 19.3 million cases and 10 million cancer deaths in 2020. Therefore, the rising prevalence of cancer drives the growth of the precision medicine market. Major players in the precision medicine market are Qiagen, Novartis AG, Medtronic, AstraZeneca plc., Quest Diagnostics, Thermo Fisher Scientific Inc., Pfizer, Bristol-Myers Squibb, Merck & Co. Inc., Tepnel Pharma Services, Abbott Laboratories, Takeda Pharmaceutical Company Ltd., and Eli Lilly and Company. The development of novel precision medicine for pancreatic cancer is shaping the precision medicine market. Extensive research is being undertaken on different approaches to develop precision medicines for pancreatic cancer. For instance, in October 2020, Scientists from the University of Glasgow announced the development of a novel precision medicine approach for treating the damaged DNA in the cancer cells of pancreatic cancer patients. The team used grown cells from the lab, and replicas of patients' tumors, to find molecular markers, which were used in the prediction and response to several drugs, targeting DNA damage. The researchers tested certain markers using multiple drugs, also developed a strategy that is taken forward into a clinical trial. The trial will help doctors and researchers to predict which patient will respond to one of these drugs, either alone or in combination. In April 2021, Servier Laboratories, a France-based pharmaceutical company acquired Agios Pharmaceuticals Inc.,’s commercial, clinical, and research-stage oncology portfolio for an undisclosed amount. The acquisition of Servier Laboratories is focused on strengthening its commercial presence in the malignant technology market and provides the potential for long-term growth into the solid tumor space. The transaction includes marketed oncology precision medicine in malignant technology, clinical oncology pipeline with multiple early-stage and phase-3 assets. Agios Pharmaceuticals is a US-based company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. North America was the largest region in the precision medicine market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the precision medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The precision medicine market consists of sales of imatinib, personalized medicine, and individualized medicine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The precision medicine market research report is one of a series of new reports from The Business Research Company that provides precision medicine market statistics, including precision medicine industry global market size, regional shares, competitors with a precision medicine market share, detailed precision medicine market segments, market trends and opportunities, and any further data you may need to thrive in the precision medicine industry. This precision medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Nanomedicine refers to the use of nanotechnology in medicine. It is described as substances with a size between 1 and 100 nanometers that, in the end, should be able to precisely target tumour cells or important immune cells. Nanomedicine is an important instrument that enables personalized, targeted, and regenerative medicine by delivering improved new drugs, treatments, and implantable devices to clinicians and patients. The main types of nanomedicine are nanoparticles, nanoshells, nanotubes, nanodevices, and others. Nanoparticles are a type of ultrafine particles usually between 1 and 100 nanometers in diameter used in making medicine and drugs. The different forms of modality include diagnostics, treatments and are used in clinical oncology, infectious diseases, clinical cardiology, orthopedics, others. The global nanomedicine market is segmented - 1) By Type: Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Other Types 2) By Modality: Diagnostics, Treatments 3) By Application: Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Other Applications The global nanomedicine market size will grow from $253.34 billion in 2022 to $287.42 billion in 2023 at a compound annual growth rate (CAGR) of 13.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the nanomedicine is expected to grow to $487.69 billion in 2027 at a CAGR of 14.1%. The rising burden of complex and chronic diseases across the globe is expected to contribute to the growth of the nanomedicine market in the forecast period. Nanomedicine is increasingly being used in treating chronic diseases including cardiovascular disorders, diabetes, cancer, dementia, and others where it helps in the fast metabolism of drugs in the body. According to the international federation of Alzheimer's associations, Alzheimer's Disease International, more than 50 million people are suffering from dementia globally, and is projected to double every 20 years, which will reach 80 million by 2030 and 152 million by 2050. In 2020, the total cancer burden in the world increased to 19.3 million new cases and is predicted to rise to 28.4 million new cancer cases in 2040. This increasing burden of chronic diseases is expected to propel the demand for effective therapeutics treatment based on nanomedicine, thus driving the growth of nanomedicine market. Major players in the nanomedicine market are Pfizer Inc., Nanotherapeutics Inc., NanoViricides Inc., Arrowhead Research Inc., Celgene Corporation, Bio-Gate AG, Merck AG, Ablynx NV, F. Hoffmann-La Roche AG, Nanospectra Biosciences, GE Healthcare, Gilead Sciences Inc., Novartis AG, Amgen Inc., and Sanofi. The 4D Nanomedicine is a key trend gaining popularity in the nanomedicine market. 4D nanomedicine is used in medical procedures for safer treatment with nanoparticles. 4D nanomedicine is made with biodegradable and biocompatible nanoalloys that do not accumulate in the body, thus, limiting the side effects. The 4D nanomedicine is accepted as a fundamental development in the treatment and diagnosis of cancer. For instance, in 2020, a research team from The Department of Chemical Sciences, University of Padua investigated and confirmed the effectiveness of inorganic 4D nanoparticles in the biomedical field. 4D nanomedicine offers several advantages to the biomedical field including reduced side effects in a living organism, minimal environmental impact, improved quality of care, and spontaneous effect. In August 2021, Sanofi S.A., a France-based pharmaceutical and healthcare company, acquired Translate Bio, Inc., for $3.2 billion. Under this acquisition, Sanofi accelerates the creation of currently approved Sanofi vaccination programs and opens up the possibility of investigating additional therapeutic fields. The mRNA Center of Excellence at Sanofi is being established more quickly. Full integration strengthens US talent in a promising new technology and improves drug formulation capabilities. Exploring the potential of this technology to create both best-in-class vaccines and treatments is further advanced by Translate Bio's addition of an mRNA technology platform and strong skills to our research. Translate Bio, Inc., is a US-based clinical stage biopharmaceutical company developing a new class of potentially game-changing drugs to treat conditions brought on by protein or gene malfunction or to stop infectious diseases by boosting immune defences. North America was the largest region in the nanomedicine market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomedicine market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the nanomedicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The nanomedicine market consists of sales of gold, silica, iron oxide, polymeric, liposomes, and micelles. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The nanomedicine market research report is one of a series of new reports from The Business Research Company that provides nanomedicine market statistics, including nanomedicine industry global market size, regional shares, competitors with a nanomedicine market share, detailed nanomedicine market segments, market trends and opportunities, and any further data you may need to thrive in the nanomedicine industry. This nanomedicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Digital therapeutics (DTx) are the products that give evidence-based therapeutic treatments to patients through high-quality software applications in order to prevent, manage, or treat a medical ailment or disease. The main product types of digital therapeutics are devices and software. Digital therapeutics devices provide intervention to prevent, manage or treat a disease or medical disorder. This includes devices such as sensors used to track medication usage and location data. The different sales channels include business-to-business (B2B), business-to-consumer (B2C). Digital therapeutics are used in preventive applications and treatment or care-related applications. The global digital therapeutics market is segmented - 1) By Product: Software, Devices 2) By Sales Channel: Business-To-Business (B2B), Business-To-Consumers (B2C) 3) By Application: Preventive Applications, Treatment Or Care-Related Applications The global digital therapeutics market size grew from $5.53 billion in 2022 to $6.93 billion in 2023 at a compound annual growth rate (CAGR) of 25.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the digital therapeutics market is expected to grow to $17.19 billion in 2027 at a CAGR of 25.5%. The increase in use of smartphones and tablets, coupled with healthcare apps, is expected to propel the growth of the digital therapeutics market in the forecast period. Smartphones and tablet-based healthcare apps have numerous advantages over the lower rate of medication errors, facilitating preventive care, and more accurate staffing. For instance, according to the Groupe Speciale Mobile Association (GSMA) report, the number of smartphone users in the US reached 270 million in 2020. According to the Pew Research Center, a nonpartisan American think tank, the percentage of Americans who own a smartphone climbed from 81% in February 2019 to 85% in February 2021, which was just 35% a decade ago (in 2011). Therefore, the increasing use of smartphones drives the growth of the digital therapeutics market. Major players in the digital therapeutics market are Omada Health Inc., WellDoc Inc., 2Morrow Inc., Livongo Health, Propeller Health, Pear Therapeutics, Canary Health Inc., Noom Health Inc., Mango Health Inc., Akili Interactive Labs, Better Therapeutics, Happify Health, Kaia Health, Medtronic PLC., Teladoc Health Inc., and Fitbit Health Solutions. Technological innovation is an emerging trend gaining popularity in the digital therapeutics market. Major companies operating in the market are focused on developing technologically advanced solutions for digital therapeutics to strengthen their position. For instance, in 2020, Boehringer Ingelheim, a Germany-based pharmaceutical company, and Click Pharmaceuticals, a US-based prescription digital therapeutics business, have agreed to collaborate on the development and commercialization of a digital medication for schizophrenia patients worth more than $500 million. The treatment named CT-155 will be a mobile app developed on click's technology platform, according to the company. In April 2020, Novartis, a Switzerland-based pharmaceutical company, acquired Ambylotech for an undisclosed amount. This acquisition is expected to help Novartis to develop Amblyotech's novel digital technology to treat amblyopia or lazy eye through digital therapeutics. Amblyotech is a US-based digital therapeutics company. North America was the largest region in the digital therapeutics market in 2022. The Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutic market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the digital therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The digital therapeutics market consists of sales of products to treat a disease, manage a condition, and improve a health function. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The digital therapeutics market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics market statistics, including digital therapeutics industry global market size, regional shares, competitors with a digital therapeutics market share, detailed digital therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics industry. This digital therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The healthcare software as a service refers to a service model in cloud computing where one or more vendors provide cloud-based remote software products to the healthcare industry. The SaaS application in healthcare can access multiple features to keep patient data secure. It allows healthcare firms to reduce unnecessary overhead costs. The main application of healthcare software as a service includes patient portal, telemedicine, mobile communication, eprescribing, HER systems, ERP systems, ERP & HR portal, and medical billing. The patient portal software or solutions provide secure access to medical records and services for the user by facilitating tasks such as scheduling appointments, requesting prescription refills, and making online bill payments. These software’s and solutions are deployed through public, private, and hybrid cloud models, and they are used by payers and providers in both large enterprises, and small-and medium enterprises. The global healthcare software as a service market is segmented - 1) By Application: Patient Portal, Telemedicine, Mobile Communication, ePrescribing, EHR Systems, ERP & HR Portal, Medical Billing 2) By Deployment Model: Private, Hybrid, Public 3) By Organization Size: Large Enterprise, Small And Medium Enterprises 4) By End-User: Provider, Payer The global healthcare software as a service market size will grow from $18.33 billion in 2022 to $21.56 billion in 2023 at a compound annual growth rate (CAGR) of 17.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the healthcare software as a service is expected to grow to $42.13 billion in 2027 at a CAGR of 18.2%. The growing adoption of cloud computing is expected to propel the growth of the healthcare software as a service market. Healthcare organizations are adopting cloud computing as the current crisis has reinforced its benefits and put to rest fears related to privacy, security, and implementation. Healthcare organizations can achieve increased data security, assured system scalability, and enhanced flexibility to manage billings and streamline claims for significant cost savings with cloud computing. For instance, in February 2022, according to a survey conducted by a UK-based consulting firm, Ernst & Young Global Limited, and an Indian non-governmental trade association, The National Association of Software and Service Companies (NASSCOM), four in every five enterprises are set to increase their cloud budgets over the next 12 months. As per the survey, 67% of the large enterprises accelerated cloud adoption, 39% of medium-sized companies, and 38% of small companies embarked on their cloud journey. IT companies lead cloud adoption, followed by the healthcare sector and the BFSI sector. Therefore, growing adoption of cloud computing is driving the healthcare software as a service market growth. Major players in the healthcare software as a service market are Microsoft Corporation, Salesforce Inc., SAP SE, Oracle Corporation, Google LLC, International Business Machines Corporation, ServiceNow, Neusoft Corporation, Adobe Inc., Cisco Systems Inc., Dell Inc., Carestream Health, Cerner Corporation, Philips Healthcare, and 3M Health. Technological advancement is a key trend that is gaining popularity in the healthcare software as a service market. Major companies operating in the healthcare SaaS market are focused on providing technologically-advanced solutions to strengthen their market position. These companies are implementing next-generation SaaS technologies into their services, such as Artificial Intelligence (AI), Vertical SaaS, Pay-Per-Use Model, IoT, Integration in existing systems, and others. For instance, in March 2022, Snowflake Inc., a US-based cloud computing and data warehousing company, launched a cloud-based data-sharing platform to bring together core SaaS data analytics, warehousing, and business intelligence offerings with consulting services on demand for the healthcare industry. In April 2021, WELL Health Technologies Corp., a Canada-based healthcare company, acquired Intrahealth Systems Limited for an amount of $19.25 million. This acquisition will help WELL Health Technologies to boost digital health SaaS revenue and expand the EMR business to the global market. Intrahealth Systems Limited is a New Zealand-based company that provides software services for the healthcare industry. North America was the largest region in the healthcare software as a service market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare software as a service market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the healthcare software as a service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The healthcare software as a service market includes revenues earned by entities by providing software development services, SaaS development, software consulting services, UI/UX design services, blockchain consulting services and AI consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The healthcare software as a service market research report is one of a series of new reports from The Business Research Company that provides healthcare software as a service market statistics, including healthcare software as a service industry global market size, regional shares, competitors with a healthcare software as a service market share, detailed healthcare software as a service market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare software as a service industry. This healthcare software as a service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Electronic Data Interchange (EDI) is the software medium for the transaction of data among various healthcare providers and payers via computer systems. The organizer can process and track claims through the entire billing cycle via the EDI service. The healthcare EDI is used to manage the patient's medical history, medication data, and emergency services record, which are considered critical data in the healthcare sector. The main types of transactions in healthcare EDI are claim management, healthcare supply chain, and others. Claim management is the organization, billing, filing, updating, and procedure of healthcare claims connected to patient diagnoses, medication, and treatment. The different components include software, hardware, and services and include various delivery modes such as mobile, VAN, web & cloud-based, and point-to-point. These are used by healthcare providers, payers, pharmacies, and other end users. The global healthcare edi market is segmented - 1) By Component: Software, Hardware, Services 2) By Transaction: Claim Management, Healthcare Supply Chain, Other Transactions 3) By Mode of Delivery: Mobile, VAN, Web & Cloud-based, Point-to-point 4) By End User: Healthcare Provider, Payer, Pharmacies, Other End Users The global healthcare edi market size grew from $4.05 billion in 2022 to $4.49 billion in 2023 at a compound annual growth rate (CAGR) of 10.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the healthcare edi market is expected to grow to $6.59 billion in 2027 at a CAGR of 10.1%. The increasing government support for healthcare is expected to propel the growth of the healthcare EDI market growing forward. Healthcare EDI is used to share information between the departments and branches in super-specialty hospitals. Healthcare EDI software helps to transmit details including coordination of benefits, claims status and information, insurance data, payment data, and eligibility forms among healthcare. Rising government support for the healthcare industry helps the healthcare sector develop new equipment and provide better services for the people. It also helps to increase technology in government hospitals. For instance, according to the Indian Economic Survey, in 2021-22, India's public healthcare spending reached 2.1%, up from 1.8% in 2020-21. Furthermore, the Union budget for 2022 allocated 11.28 billion for the growth of health care. Therefore, the increasing government support for healthcare drives the demand for the healthcare EDI market. Major players in the healthcare EDI market are McKesson Corporation, Optum, Allscripts, GE Healthcare, Cognizant, Cerner, Dell Technologies Inc., The SSI Group, Tallan Inc., Quadax, AthenaHealth, Schreiner Group, MuleSoft LLC, and Boomi. Technological advancements have emerged as the key trend gaining popularity in the healthcare EDI market. Major companies operating in the healthcare EDI market are focused on new technological innovations to sustain their position in the market. For instance, in 2020, Waystar, a US-based company that develops a technology platform that simplifies and unifies the healthcare payments cycle, launched its new analytics software based on revenue cycle technology. It facilitates access to vital data insights and aids medical organizations during the pandemic situation. Waystar fast-tracked the launch of this new software, which offers the intelligence healthcare leaders require to make strategic, reliable, and correct decisions in this environment. In August 2020, Waystar, a US-based company that develops a cloud-based revenue cycle management platform and healthcare solutions acquired eSolutions for a deal amount of $1.3 billion. Through this acquisition, Waystar would combine both commercial and government payers into a single payment platform. This acquisition also helps Waystar to deliver outstanding innovation to the industry, helping healthcare organizations to accelerate income collection while reducing administrative costs and redundant tasks. eSolutions is a US-based healthcare technology company that develops revenue cycles. North America was the largest region in the healthcare EDI market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare EDI market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the healthcare EDI market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The healthcare electronic data interchange (EDI) market includes revenues earned by Web & Cloud-based EDI, EDI Value Added Network, Direct EDI and Mobile EDI. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The healthcare EDI market research report is one of a series of new reports from The Business Research Company that provides healthcare EDI market statistics, including healthcare EDI industry global market size, regional shares, competitors with a healthcare EDI market share, detailed healthcare EDI market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare EDI industry. This healthcare EDI market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.